Indra Tumur

1.0k total citations
11 papers, 812 citations indexed

About

Indra Tumur is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Indra Tumur has authored 11 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Indra Tumur's work include Lipoproteins and Cardiovascular Health (4 papers), Pharmaceutical Economics and Policy (3 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers). Indra Tumur is often cited by papers focused on Lipoproteins and Cardiovascular Health (4 papers), Pharmaceutical Economics and Policy (3 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers). Indra Tumur collaborates with scholars based in United Kingdom and United States. Indra Tumur's co-authors include Michael Ferriter, Glenys Parry, Suzy Paisley, John Brazier, Paul Sutcliffe, Catherine Beverley, Eva Kaltenthaler, Roberta Ara, Alejandra Duenas and J. Chilcott and has published in prestigious journals such as Journal of Internal Medicine, Health Technology Assessment and Clinical Therapeutics.

In The Last Decade

Indra Tumur

11 papers receiving 777 citations

Peers

Indra Tumur
Michelle K. White United States
Rute Vieira United Kingdom
Dounya Schoormans Netherlands
Betty Tai United States
Quang A. Le United States
Stacey L. Tannenbaum United States
Indra Tumur
Citations per year, relative to Indra Tumur Indra Tumur (= 1×) peers Qiuying Han

Countries citing papers authored by Indra Tumur

Since Specialization
Citations

This map shows the geographic impact of Indra Tumur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Indra Tumur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Indra Tumur more than expected).

Fields of papers citing papers by Indra Tumur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Indra Tumur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Indra Tumur. The network helps show where Indra Tumur may publish in the future.

Co-authorship network of co-authors of Indra Tumur

This figure shows the co-authorship network connecting the top 25 collaborators of Indra Tumur. A scholar is included among the top collaborators of Indra Tumur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Indra Tumur. Indra Tumur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Larkin, James, Indra Tumur, Joseph C. Cappelleri, et al.. (2012). Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis. Expert Opinion on Pharmacotherapy. 14(1). 27–39. 19 indexed citations
2.
Beresford, Mark, Indra Tumur, J. Chakrabarti, et al.. (2010). A Qualitative Systematic Review of the Evidence Base for Non-cross-resistance between Steroidal and Non-steroidal Aromatase Inhibitors in Metastatic Breast Cancer. Clinical Oncology. 23(3). 209–215. 21 indexed citations
3.
Ara, Roberta, Indra Tumur, Abdullah Pandor, et al.. (2008). Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation. Health Technology Assessment. 12(21). iii, xi–xiii, 1. 53 indexed citations
4.
Ara, Roberta, Abdullah Pandor, Indra Tumur, et al.. (2008). Cost Effectiveness of Ezetimibe in Patients with Cardiovascular Disease and Statin Intolerance or Contraindications. American Journal of Cardiovascular Drugs. 8(6). 419–427. 20 indexed citations
6.
Pandor, Abdullah, Roberta Ara, Indra Tumur, et al.. (2008). Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta‐analysis of randomized controlled trials. Journal of Internal Medicine. 265(5). 568–580. 162 indexed citations
7.
Hind, Daniel, Paul Tappenden, Indra Tumur, et al.. (2008). The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation. Health Technology Assessment. 12(15). iii–ix, xi. 64 indexed citations
8.
Tumur, Indra, Eva Kaltenthaler, Michael Ferriter, Catherine Beverley, & Glenys Parry. (2007). Computerised Cognitive Behaviour Therapy for Obsessive-Compulsive Disorder: A Systematic Review. Psychotherapy and Psychosomatics. 76(4). 196–202. 42 indexed citations
9.
Brazier, John, Indra Tumur, Michael Ferriter, et al.. (2006). Psychological therapies including dialectical behaviour therapy for borderline personality disorder: a systematic review and preliminary economic evaluation. Health Technology Assessment. 10(35). iii, ix–xii, 1. 112 indexed citations
10.
Kaltenthaler, Eva, John Brazier, Enrico De Nigris, et al.. (2006). Computerised cognitive behaviour therapy for depression and anxiety update: a systematic review and economic evaluation. Health Technology Assessment. 10(33). iii, xi–xiv, 1. 282 indexed citations
11.
Hind, Daniel, et al.. (2005). Technology assessment report commissioned by the HTA Programme on behalf of The National Institute for Clinical Excellence The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation (review of Guidance No. 33) Addendum: Economic evaluation of irinotecan and oxaliplatin for the treatment of advanced colorectal cancer. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026